ArticleCase reports in dermatology

A Case of Erythema Multiforme Major Developed after Sequential Use of Two Immune Checkpoint Inhibitors, Nivolumab and Ipilimumab, for Advanced Melanoma: Possible Implication of Synergistic and/or Complementary Immunomodulatory Effects.

Akira Utsunomiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.